ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $440,000 | +32.9% | 26,200 | -2.7% | 0.12% | +236.1% |
| Q3 2017 | $331,000 | -7.0% | 26,923 | -36.7% | 0.04% | -16.3% |
| Q2 2017 | $356,000 | -79.6% | 42,542 | -78.2% | 0.04% | -80.0% |
| Q1 2017 | $1,744,000 | +14.5% | 195,030 | +12.6% | 0.22% | -20.4% |
| Q4 2016 | $1,523,000 | +18.1% | 173,230 | -9.4% | 0.27% | -10.9% |
| Q3 2016 | $1,290,000 | +148.6% | 191,130 | +31.1% | 0.30% | +133.1% |
| Q2 2016 | $519,000 | +222.4% | 145,788 | +167.0% | 0.13% | +150.0% |
| Q1 2016 | $161,000 | +6.6% | 54,600 | +52.1% | 0.05% | -42.9% |
| Q4 2015 | $151,000 | – | 35,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |